Physicians Brace for Drug, Device 'Transparency'
Prior efforts to increase disclosure of industry-physicians financial relationship include a 2009 Institute of Medicine report, that developed recommendations "to identify, limit and manage without affecting constructive collaborations with industry and called for broad public transparency," according to the NEJE report.
The Physician Payment Sunshine Act was created by Congress to ensure transparency in physicians' interactions with the pharmaceutical, biologic and medical device industries as well as group purchasing organizations.
The law covers meals, honoraria, travel expenses, and grants from manufacturers, and ownership and investment interests by physicians or members of their immediate family. Eventually, physicians who have received payments or hold ownership will be posted on a website, under the National Physician Payment Transparency Program of the CMS.
The AMA is offering doctors a Physician Sunshine Act Tool Kit to help navigate the changes.
Joe Cantlupe is a senior editor with HealthLeaders Media Online.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- 3 Traits Personality Assessments Can't Reveal
- Antibiotic Overuse a 'Huge Threat' to Patient Safety, Says CDC
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- CHS Hacked, 4.5M Patient Records Compromised
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- CFO Exchange: Healthcare Leaders Share 5 Innovative Ideas
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- Carondelet to Pay $35M to Settle Fraud Allegations